Adriaan Bionics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-12-2024
- Paid Up Capital ₹ 2.50 M
as on 18-12-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 74977.18%
(FY 2023)
- Profit -52424.16%
(FY 2023)
- Ebitda -50583.50%
(FY 2023)
- Net Worth 96577.33%
(FY 2023)
- Total Assets 98531.01%
(FY 2023)
About Adriaan Bionics
The Corporate was formerly known as Veronik Bionics Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Kulkarni, Pramod Naik, Sagar Khedekar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24244GA1995PTC001953
- Company No.
001953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 1995
- Date of AGM
25 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Adriaan Bionics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Kulkarni  | Director | 01-Jan-2019 | Current |
| Pramod Naik | Director | 12-Dec-2018 | Current |
| Sagar Khedekar | Director | 11-Aug-2021 | Current |
| Gauresh Kaloji | Director | 01-Jul-2024 | Current |
Financial Performance of Adriaan Bionics.
Adriaan Bionics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74977.18% increase. The company also saw a substantial fall in profitability, with a 52424.16% decrease in profit. The company's net worth Soared by an impressive increase of 96577.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adriaan Bionics?
In 2023, Adriaan Bionics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Micnelf Micronutrients Private LimitedActive 50 years 6 monthsAjit Kulkarni and Sagar Khedekar are mutual person
Kiecite Micronutrients Private LimitedActive 31 years 9 daysAjit Kulkarni, Pramod Naik and 1 more are mutual person
Satrite Manusec Private LimitedActive 35 years 2 monthsAjit Kulkarni and Sagar Khedekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adriaan Bionics?
Unlock and access historical data on people associated with Adriaan Bionics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adriaan Bionics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adriaan Bionics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
